16755177

Source:http://linkedlifedata.com/resource/pubmed/id/16755177

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0030705, umls-concept:C0079459, umls-concept:C0144576, umls-concept:C0146224, umls-concept:C0183683, umls-concept:C0205390, umls-concept:C0210630, umls-concept:C0278726, umls-concept:C0344211, umls-concept:C0442027, umls-concept:C1171411, umls-concept:C1317973, umls-concept:C1518419, umls-concept:C1521721
pubmed:issue	3
pubmed:dateCreated	2006-6-6
pubmed:abstractText	To determine the efficacy and toxicity of oral topotecan and paclitaxel in untreated patients with extensive stage small cell lung cancer (SCLC).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-15083, http://linkedlifedata.com/resource/pubmed/grant/CA-25224, http://linkedlifedata.com/resource/pubmed/grant/CA-35103, http://linkedlifedata.com/resource/pubmed/grant/CA-35195, http://linkedlifedata.com/resource/pubmed/grant/CA-35431, http://linkedlifedata.com/resource/pubmed/grant/CA-35448, http://linkedlifedata.com/resource/pubmed/grant/CA-35629, http://linkedlifedata.com/resource/pubmed/grant/CA-37404, http://linkedlifedata.com/resource/pubmed/grant/CA-37417, http://linkedlifedata.com/resource/pubmed/grant/CA-CA-63849
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8207754
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Topotecan
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1537-453X
pubmed:author	pubmed-author:BernathAlbert MAMJr, pubmed-author:CarrollThomas JTJ, pubmed-author:FosterNathanN, pubmed-author:HillmanShaunaS, pubmed-author:JettJames RJR, pubmed-author:LairBradley SBS, pubmed-author:MailliardJames AJA, pubmed-author:MolinaJulian RJR, pubmed-author:NikcevichDanielD, pubmed-author:TazelaarHenry DHD
pubmed:issnType	Electronic
pubmed:volume	29
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	246-51
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16755177-Administration, Oral, pubmed-meshheading:16755177-Adult, pubmed-meshheading:16755177-Aged, pubmed-meshheading:16755177-Aged, 80 and over, pubmed-meshheading:16755177-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16755177-Carcinoma, Small Cell, pubmed-meshheading:16755177-Disease Progression, pubmed-meshheading:16755177-Female, pubmed-meshheading:16755177-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:16755177-Humans, pubmed-meshheading:16755177-Infusions, Intravenous, pubmed-meshheading:16755177-Injections, Subcutaneous, pubmed-meshheading:16755177-Lung Neoplasms, pubmed-meshheading:16755177-Male, pubmed-meshheading:16755177-Middle Aged, pubmed-meshheading:16755177-Paclitaxel, pubmed-meshheading:16755177-Survival Analysis, pubmed-meshheading:16755177-Topotecan, pubmed-meshheading:16755177-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Phase II NCCTG trial of oral topotecan and paclitaxel with G-CSF (filgrastim) support in patients with previously untreated extensive-stage small cell lung cancer.
pubmed:affiliation	Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Phase II, Research Support, N.I.H., Extramural